Valve
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about the EACTS expert consensus document...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...
The authors present a case of post-myocardial infarction ventricular pseudoaneurysm repair with mitral valve replacement and coronary revascularization performed through a minimally invasive left anterior minithoracotomy via the fourth intercostal...
Wednesday, November 18, 2026 @ 7:00 am – 8:00 am – This CTSNet Guest Editor Series, led by Tianyang Yang of Shanghai 4th People’s Hospital, Shanghai, China, presents clinical videos...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University...
A 16-year-old male presented with shortness of breath and exertional fatigue. He had a history of repeat hospitalization due to acute episodes of suspected pulmonary edema. He had previously undergone...
This 2026 joint expert consensus document from the Society of Thoracic Surgeons (STS), the World Society for Pediatric and Congenital Heart Surgery, and the European Congenital Heart Surgeons Association addresses...
This US Food and Drug Administration (FDA)-approved prospective, single-arm, multicenter early feasibility study evaluated the Autus Size-Adjustable Valve (ASAV), a surgically implanted, fully synthetic, balloon-expandable pulmonary valve for children requiring...
Functional (secondary) mitral regurgitation (MR) commonly accompanies aortic valve pathology as a consequence of left ventricular dilatation, which increases interpapillary muscle distance and impairs mitral leaflet coaptation. While correction of...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San...
This single-center retrospective study evaluated long-term outcomes after surgical aortic valve replacement with the Perimount Magna Ease bioprosthesis in 1,907 patients at 12 years of follow-up. Thirty-day mortality was 2.8...
Valve-in-valve transcatheter aortic valve implantation (TAVI) is a valuable therapeutic option for managing degenerated bioprosthetic valves, particularly in elderly, high-risk patients. However, careful patient selection and thorough anatomical assessment are...
This retrospective study evaluated surgical mitral valve interventions in 221 octogenarians (median age 82) at a high-volume center, addressing concerns regarding procedural risk in the elderly. The cohort achieved an...






